Table 1.
Baseline demographics (n = 57)
Mean age at treatment, in years (range) | 59 (26–84)a |
Sex | |
Male | 30 (53) |
Female | 27 (47) |
Had chemotherapy been administered prior to bevacizumab? | |
Yes | 40 (70) |
No | 17 (30) |
Weight loss at time of cancer diagnosis? | |
Yes | 14 (25) |
No | 15 (26) |
Unknown | 28 (49) |
Diabetes? | |
Yes | 10 (18) |
No | 47 (82) |
Numbers in parentheses refer to the percentage of the cohort unless otherwise specified